John G. Lemkey, Officer, Chief Financial Officer, Chief Executive Officer, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 15,010 shares at $19.47 ($292K) on 2018-08-21, disclosed to the SEC on 2018-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.47 | 7,505 | $146K | 50.0% |
| 2 | $19.47 | 7,505 | $146K | 50.0% |
| Total | $19.47 avg | 15,010 | $292K | 100% |
| Filing → |
| ODT | BUY | 2019-03-11 | $4.7M | — | Filing → |
| ODT | BUY | 2018-12-26 | $756K | — | Filing → |
| ODT | BUY | 2018-12-18 | $848K | — | Filing → |